$22.80 -0.16 (-0.70%)
2/10/2012 4:00 PM

Mylan Laboratories, Inc. (NASDAQ:MYL)

CAPS Rating: 4 out of 5

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

Featured Broker Partners


Advertisement